Institution
Sungkyunkwan University
Education•Seoul, South Korea•
About: Sungkyunkwan University is a education organization based out in Seoul, South Korea. It is known for research contribution in the topics: Graphene & Thin film. The organization has 28229 authors who have published 56428 publications receiving 1352733 citations. The organization is also known as: 성균관대학교.
Topics: Graphene, Thin film, Population, Carbon nanotube, Layer (electronics)
Papers published on a yearly basis
Papers
More filters
••
Harvard University1, Seoul National University2, Kindai University3, Sungkyunkwan University4, Institut Gustave Roussy5, Peter MacCallum Cancer Centre6, Heidelberg University7, Trinity College, Dublin8, Joseph Fourier University9, University of Colorado Boulder10, The Chinese University of Hong Kong11, McGill University12, Memorial Sloan Kettering Cancer Center13, Pfizer14
TL;DR: Crizotinib is superior to standard chemotherapy in patients with previously treated, advanced non-small-cell lung cancer with ALK rearrangement and greater improvement in global quality of life with crizotinIB than with chemotherapy.
Abstract: BACKGROUND: In single-group studies, chromosomal rearrangements of the anaplastic lymphoma kinase gene (ALK ) have been associated with marked clinical responses to crizotinib, an oral tyrosine kinase inhibitor targeting ALK. Whether crizotinib is superior to standard chemotherapy with respect to efficacy is unknown. METHODS: We conducted a phase 3, open-label trial comparing crizotinib with chemotherapy in 347 patients with locally advanced or metastatic ALK-positive lung cancer who had received one prior platinum-based regimen. Patients were randomly assigned to receive oral treatment with crizotinib (250 mg) twice daily or intravenous chemotherapy with either pemetrexed (500 mg per square meter of body-surface area) or docetaxel (75 mg per square meter) every 3 weeks. Patients in the chemotherapy group who had disease progression were permitted to cross over to crizotinib as part of a separate study. The primary end point was progression-free survival. RESULTS: The median progression-free survival was 7.7 months in the crizotinib group and 3.0 months in the chemotherapy group (hazard ratio for progression or death with crizotinib, 0.49; 95% confidence interval [CI], 0.37 to 0.64; P<0.001). The response rates were 65% (95% CI, 58 to 72) with crizotinib, as compared with 20% (95% CI, 14 to 26) with chemotherapy (P<0.001). An interim analysis of overall survival showed no significant improvement with crizotinib as compared with chemotherapy (hazard ratio for death in the crizotinib group, 1.02; 95% CI, 0.68 to 1.54; P=0.54). Common adverse events associated with crizotinib were visual disorder, gastrointestinal side effects, and elevated liver aminotransferase levels, whereas common adverse events with chemotherapy were fatigue, alopecia, and dyspnea. Patients reported greater reductions in symptoms of lung cancer and greater improvement in global quality of life with crizotinib than with chemotherapy. CONCLUSIONS: Crizotinib is superior to standard chemotherapy in patients with previously treated, advanced non-small-cell lung cancer with ALK rearrangement. (Funded by Pfizer; ClinicalTrials.gov number, NCT00932893.) Copyright © 2013 Massachusetts Medical Society.
3,074 citations
••
Imperial College London1, University of Barcelona2, Keio University3, University of Duisburg-Essen4, Queen's University5, Peter MacCallum Cancer Centre6, University of Michigan7, University of São Paulo8, Yale University9, Northern General Hospital10, University of Caen Lower Normandy11, Fred Hutchinson Cancer Research Center12, University of Oxford13, Memorial Sloan Kettering Cancer Center14, University of Sydney15, Sungkyunkwan University16, Seoul National University17, Kyorin University18, University of Copenhagen19, Nippon Medical School20, Katholieke Universiteit Leuven21, University of Texas MD Anderson Cancer Center22, University of Antwerp23, Hyogo College of Medicine24, University of Western Australia25, Glenfield Hospital26, Cleveland Clinic27, Icahn School of Medicine at Mount Sinai28, University of Turin29, Université libre de Bruxelles30, Juntendo University31, National Cancer Research Institute32, Mayo Clinic33, University of Toronto34, Sinai Grace Hospital35, Netherlands Cancer Institute36, Hiroshima University37, City of Hope National Medical Center38, University of Chicago39, New York University40, Georgetown University41, University of Tokushima42, University of Pisa43, Osaka University44, University of Valencia45, Good Samaritan Hospital46, Military Medical Academy47, Fundación Favaloro48, Autonomous University of Barcelona49, Complutense University of Madrid50, University of Oviedo51, National and Kapodistrian University of Athens52, Rovira i Virgili University53, Autonomous University of Madrid54, Ghent University55
TL;DR: The methods used to evaluate the resultant Stage groupings and the proposals put forward for the 8th edition of the TNM Classification for lung cancer due to be published late 2016 are described.
2,826 citations
••
TL;DR: Perovskite QD-sensitized 3.6 μm-thick TiO(2) film shows maximum external quantum efficiency (EQE) of 78.6% at 530 nm and solar-to-electrical conversion efficiency of 6.54% at AM 1.5G 1 sun intensity (100 mW cm(-2)), which is by far the highest efficiency among the reported inorganic quantum dot sensitizers.
Abstract: Highly efficient quantum-dot-sensitized solar cell is fabricated using ca. 2–3 nm sized perovskite (CH3NH3)PbI3 nanocrystal. Spin-coating of the equimolar mixture of CH3NH3I and PbI2 in γ-butyrolactone solution (perovskite precursor solution) leads to (CH3NH3)PbI3 quantum dots (QDs) on nanocrystalline TiO2 surface. By electrochemical junction with iodide/iodine based redox electrolyte, perovskite QD-sensitized 3.6 μm-thick TiO2 film shows maximum external quantum efficiency (EQE) of 78.6% at 530 nm and solar-to-electrical conversion efficiency of 6.54% at AM 1.5G 1 sun intensity (100 mW cm−2), which is by far the highest efficiency among the reported inorganic quantum dot sensitizers.
2,781 citations
••
TL;DR: This survey makes an exhaustive review of wireless evolution toward 5G networks, including the new architectural changes associated with the radio access network (RAN) design, including air interfaces, smart antennas, cloud and heterogeneous RAN, and underlying novel mm-wave physical layer technologies.
Abstract: The vision of next generation 5G wireless communications lies in providing very high data rates (typically of Gbps order), extremely low latency, manifold increase in base station capacity, and significant improvement in users’ perceived quality of service (QoS), compared to current 4G LTE networks. Ever increasing proliferation of smart devices, introduction of new emerging multimedia applications, together with an exponential rise in wireless data (multimedia) demand and usage is already creating a significant burden on existing cellular networks. 5G wireless systems, with improved data rates, capacity, latency, and QoS are expected to be the panacea of most of the current cellular networks’ problems. In this survey, we make an exhaustive review of wireless evolution toward 5G networks. We first discuss the new architectural changes associated with the radio access network (RAN) design, including air interfaces, smart antennas, cloud and heterogeneous RAN. Subsequently, we make an in-depth survey of underlying novel mm-wave physical layer technologies, encompassing new channel model estimation, directional antenna design, beamforming algorithms, and massive MIMO technologies. Next, the details of MAC layer protocols and multiplexing schemes needed to efficiently support this new physical layer are discussed. We also look into the killer applications, considered as the major driving force behind 5G. In order to understand the improved user experience, we provide highlights of new QoS, QoE, and SON features associated with the 5G evolution. For alleviating the increased network energy consumption and operating expenditure, we make a detail review on energy awareness and cost efficiency. As understanding the current status of 5G implementation is important for its eventual commercialization, we also discuss relevant field trials, drive tests, and simulation experiments. Finally, we point out major existing research issues and identify possible future research directions.
2,624 citations
••
TL;DR: In this paper, a layered sandwich-type architecture is proposed for next-generation dye-sensitized solar cells, which consists of a bicontinuous three-dimensional nanocomposite of mesoporous (mp)-TiO2,w ith CH 3NH3PbII3 perovskite as light harvester, as well as a polymeric hole conductor.
Abstract: Inorganic‐organic hybrid structures have become innovative alternatives for next-generation dye-sensitized solar cells, because they combine the advantages of both systems. Here, we introduce a layered sandwich-type architecture, the core of which comprises a bicontinuous three-dimensional nanocomposite of mesoporous (mp)-TiO2 ,w ith CH 3NH3PbI3 perovskite as light harvester, as well as a polymeric hole conductor. This platform creates new opportunities for the development of low-cost, solution-processed, high-efficiency solar cells. The use of a polymeric hole conductor, especially poly-triarylamine, substantially improves the open-circuit voltage V oc and fill factor of the cells. Solar cells based on these inorganic‐organic hybrids exhibit a short-circuit current density Jsc of 16.5 mA cm 22 , Voc of 0.997 V and fill factor of 0.727, yielding a power conversion efficiency of 12.0% under standard AM 1.5 conditions.
2,461 citations
Authors
Showing all 28506 results
Name | H-index | Papers | Citations |
---|---|---|---|
Michael Grätzel | 248 | 1423 | 303599 |
Hyun-Chul Kim | 176 | 4076 | 183227 |
Yongsun Kim | 156 | 2588 | 145619 |
David J. Mooney | 156 | 695 | 94172 |
Jongmin Lee | 150 | 2257 | 134772 |
Byung-Sik Hong | 146 | 1557 | 105696 |
Inkyu Park | 144 | 1767 | 109433 |
Y. Choi | 141 | 1631 | 98709 |
Kazunori Kataoka | 138 | 908 | 70412 |
E. J. Corey | 136 | 1377 | 84110 |
Pasi A. Jänne | 136 | 685 | 89488 |
Suyong Choi | 135 | 1495 | 97053 |
Intae Yu | 134 | 1372 | 89870 |
Tae Jeong Kim | 132 | 1420 | 93959 |
Anders Hagfeldt | 129 | 600 | 79912 |